Clinical trial
A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With…
NCT00109226 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00109226 |
|---|---|
| Title | A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer |
| Official title | A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab), a Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, in Combination With 5-Fluorouracil and Leucovorin Chemotherapy in… |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Avastin (Bevacizumab) |
| Start date | Aug 1, 2000 |
| Completion | Sep 1, 2003 |
| First posted | Apr 26, 2005 |
| Last update posted | Apr 8, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: